IllumiNeuro Blend

IllumiNeuro Blend Cognitive & Nootropic Overview

IllumiNeuro Blend is a meticulously engineered neurotrophic compound for synaptic growth, neuronal protection, and optimized cerebral signaling.

Physiochemical Profile

Parameter	Value
Formula	PE-22-28 + Pinealon + NA Semax + NA Selank
Mass	Synergistic Neuro Complex
Purity	>98.5% Comb.
Appearance	White lyophilized cake

Figure 1: IllumiNeuro Blend Neurological Pathway

Cerebral Mechanism of Action

1. Combines four distinct neurotrophic and neuroprotective peptides into one unified stack.
2. PE-22-28 rapidly modulates the TREK-1 channel boosting baseline mood.
3. Pinealon restores pineal gland melatonin output normalizing the sleep-wake cycle.
4. N-Acetyl Semax Amidate drives massive BDNF expression for synaptic growth.
5. N-Acetyl Selank Amidate crushes anxiety by stabilizing enkephalin turnover rates.

Figure 2: Synaptogenesis Rate

Research Outcomes

• 1: The apex nootropic stack for comprehensive cognitive and emotional optimization.
• 2: Simultaneously addresses mood, focus, anxiety, and sleep in a single reconstitution.
• 3: Each component is enzymatically armored for maximum blood-brain barrier penetration.

Multi-Peptide Nootropic Stack Design

The IllumiNeuro Blend is a pre-formulated combination of complementary nootropic peptides designed to simultaneously target multiple cognitive enhancement pathways. By combining peptides that act on neurotrophic signaling (BDNF/NGF), neurotransmitter modulation (serotonergic/dopaminergic/GABAergic), and neuroprotection (anti-excitotoxic/antioxidant), the blend aims to achieve cognitive effects greater than any single peptide can produce. The multi-target approach reflects the understanding that cognitive performance depends on the coordinated function of multiple neurotransmitter systems.

1. Neurotrophic components (Semax-derived) upregulate BDNF and NGF expression, promoting synaptic plasticity and long-term memory consolidation.
2. Anxiolytic components (Selank-derived) enhance GABAergic inhibitory tone, reducing anxiety-related interference with cognitive performance.
3. Dopaminergic modulation improves prefrontal cortex executive function, working memory, and attentional focus.
4. Serotonergic stabilization reduces impulsivity and improves mood stability, creating optimal emotional conditions for sustained cognitive work.
5. The pre-blended format ensures consistent peptide ratios optimized through preclinical dose-response characterization.

Research Advantages of Blended Nootropic Peptides

• Synergy: Peptides targeting non-overlapping receptor systems (TrkB, GABA-A, tuftsin receptor) produce additive or synergistic cognitive effects without competitive interference.
• Balanced Profile: The combination of stimulating (Semax-type) and calming (Selank-type) components produces focused alertness without overstimulation or anxiety.
• Convenience: Pre-blended formulation eliminates the need to reconstitute and administer multiple peptides separately, reducing preparation complexity and contamination risk.
• Dosing: Intranasal administration. The blend is designed for daily use during cognitive-demanding periods. Typical research course: 14–30 days, followed by a washout period.
• Storage: Store lyophilized at −20°C. Reconstitute with bacteriostatic water. Refrigerate after reconstitution and use within 28 days.